Science Explorer Back to mapMap
Discussion
Company · Mississauga · Canada

NeurAxon (Canada)

Research works
16
fractional, all time
Citations
362
22.3 per fractional work
Top-10% rate
8.8%
all institutions 10.0%
Open access
50%
world 40%
International
34%
world 18%

Not ranked overall: NeurAxon (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NeurAxon (Canada) work in?

In all years, 44% of research at NeurAxon (Canada) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (35%), Chemistry (13%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 7 fractional works · 43.7% of its workMedicine: 7 fractional works · 43.2% of its workPhysiology: 4 fractional works · 26.0% of its workPsychiatry and Mental health: 1 fractional works · 6.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 4.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.5% of its workPathology and Forensic Medicine: 0 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.7% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 7 fractional works · 41.0% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 35.2% of its workMolecular Biology: 2 fractional works · 13.0% of its workBiochemistry: 2 fractional works · 10.9% of its workBiophysics: 1 fractional works · 7.2% of its workGenetics: 1 fractional works · 4.1% of its workNeuroscience: 1 fractional works · 3.8% of its workBehavioral Neuroscience: 0 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.0% of its workPharmacology: 0 fractional works · 2.0% of its workPhysical Sciences: 2 fractional works · 13.3% of its workChemistry: 2 fractional works · 13.3% of its workOrganic Chemistry: 2 fractional works · 12.3% of its workInorganic Chemistry: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 2.0% of its workPsychology: 0 fractional works · 2.0% of its workSocial Psychology: 0 fractional works · 2.0% of its workALL ITS WORKNeurAxon (Canada)16fractional works, all years
Life Sciences41%Physical Sciences13%Health Sciences44%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine743.2%
    2. Nursing00.4%
    3. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology635.2%
    2. Neuroscience13.8%
    3. Pharmacology, Toxicology and Pharmaceutics02.0%
    1. Chemistry213.3%
    1. Psychology02.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at NeurAxon (Canada)?

Ranked on the quality score, Shawn P. Maddaford, Jailall Ramnauth and Suman Rakhit lead among researchers whose main affiliation is NeurAxon (Canada).

  1. 1 Shawn P. Maddaford Canada · #1,932,041 worldwide 1.2k citations · 46 works
  2. 2 Jailall Ramnauth Canada · #3,110,327 worldwide 635 citations · 39 works
  3. 3 Suman Rakhit Canada · #3,837,487 worldwide 834 citations · 34 works
  4. 4 Subhash C. Annedi Canada · #4,395,776 worldwide 375 citations · 23 works
  5. 5 Paul Renton Canada · #4,878,433 worldwide 315 citations · 26 works
All ranked researchers at NeurAxon (Canada)

What are the most cited papers from NeurAxon (Canada)?

The most cited paper from NeurAxon (Canada) is "Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers" (Milena De Felice, Michael H. Ossipov, R. Wang et al., 2010), with 125 citations. Next come "NXN-188, a selective nNOS inhibitor and a 5-HT 1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models" (55) and "Discovery ofcis-N-(1-(4-(Methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: A 1,6-Disubstituted Indoline Derivative as a Highly Selective Inhibitor of Human Neuronal Nitric Oxide Synthase (nNOS) without Any Cardiovascular Liabilities" (40).

Most cited papers
#PaperReleasedCitations
1 Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers Milena De Felice, Michael H. Ossipov, R. Wang et al. · Brain Open access 13 Jul 2010 125
2 NXN-188, a selective nNOS inhibitor and a 5-HT 1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models Deepak Kumar Bhatt, Saurabh Kumar Gupta, Inger Jansen‐Olesen et al. · Cephalalgia Open access 15 Nov 2012 55
3 Discovery ofcis-N-(1-(4-(Methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: A 1,6-Disubstituted Indoline Derivative as a Highly Selective Inhibitor of Human Neuronal Nitric Oxide Synthase (nNOS) without Any Cardiovascular Liabilities Subhash C. Annedi, Jailall Ramnauth, Shawn P. Maddaford et al. · Journal of Medicinal Chemistry Open access 16 Dec 2011 40
4 Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors Joanne Patman, Namrta Bhardwaj, Jailall Ramnauth et al. · Bioorganic & Medicinal Chemistry Letters Open access 9 Feb 2007 33
5 Design, Synthesis, and Biological Evaluation of 3,4-Dihydroquinolin-2(1H)-one and 1,2,3,4-Tetrahydroquinoline-Based Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors Jailall Ramnauth, Joanne Speed, Shawn P. Maddaford et al. · Journal of Medicinal Chemistry Open access 23 Jun 2011 32
All 21 most cited papers, with filters and sorting

Which research topics does NeurAxon (Canada) publish most on?

By volume in 2022-now: Trigeminal Neuralgia and Treatments, Migraine and Headache Studies, Spine and Intervertebral Disc Pathology and Cardiovascular and exercise physiology.

  1. 1 Trigeminal Neuralgia and Treatments Pathology and Forensic Medicine 0 works
  2. 2 Migraine and Headache Studies Psychiatry and Mental health 0 works
  3. 3 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
  4. 4 Cardiovascular and exercise physiology Complementary and alternative medicine 0 works
  5. 5 Sodium Intake and Health Nutrition and Dietetics 0 works
  6. 6 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  7. 7 Cervical and Thoracic Myelopathy Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.1%not open49.9%

World: 40% of research is openly available.

with international co-authors34.2%domestic only65.8%

World: 18% is written across borders.

How has NeurAxon (Canada)'s research output changed?

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is NeurAxon (Canada) as a percentage of every work published that year, 0.0000031% in 2024.

still counting0.000050%0.00010%0.00015%NeurAxon (Canada)0.0000068% in 202520102020

Fractional works of NeurAxon (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NeurAxon (Canada). Posts are plain text and can be reported.